Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

03/04/2024

Apr 3, 2024 1:04 pm

Apr 3, 2024 12:55 pm

Apr 3, 2024 12:51 pm

Apr 3, 2024 12:46 pm

Apr 3, 2024 6:35 am

Apr 3, 2024 6:29 am

Apr 3, 2024 6:22 am

Apr 3, 2024 6:09 am

Apr 3, 2024 6:05 am

Apr 3, 2024 5:58 am

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

03/04/2024

Amalya Sargsyan: Small team, big goals! This year our Yeolyan Oncology and Hematology Center team had 9 abstracts accepted at ASCO24

Madhukar Pai: Global oncology follows the familiar pattern

Claudia Batz: The WHO NCD Lab is back for a new term, with a new cycle launching very soon

Nationally ranked athlete to help other kids who have osteosarcoma – The Osteosarcoma Institute

Pashtoon Kasi: ctDNA kinetics is going to be an important variable to look at in patients getting novel immunotherapy drugs like the BOT/BAL on our NEST trial

Lillian Siu: Submit an abstract by 11:59 PM ET April 9 for ASCOBT24

Rahul Gosain: I’m happy to share that I’ve completed my Master of Business Administration in Helathcare, Tech, and Leadership at The Johns Hopkins University – Carey Business School!

Aruni Ghose: Wonderful friend and academic teammate Shania Makker is bagging the “Best Poster Award” at the ESMO ELCC2024 in Prague

Most viewed in the last 7 days from JAMA Oncology

Matteo Lambertini: Super proud of our University of Genoa, San Martino Polyclinic Hospital group and grateful for the opportunity to actively contribute to ASCO24

Headlines

03/04/2024

Amalya Sargsyan: Small team, big goals! This year our Yeolyan Oncology and Hematology Center team had 9 abstracts accepted at ASCO24

Madhukar Pai: Global oncology follows the familiar pattern

Claudia Batz: The WHO NCD Lab is back for a new term, with a new cycle launching very soon

Nationally ranked athlete to help other kids who have osteosarcoma – The Osteosarcoma Institute

Pashtoon Kasi: ctDNA kinetics is going to be an important variable to look at in patients getting novel immunotherapy drugs like the BOT/BAL on our NEST trial

Lillian Siu: Submit an abstract by 11:59 PM ET April 9 for ASCOBT24

Rahul Gosain: I’m happy to share that I’ve completed my Master of Business Administration in Helathcare, Tech, and Leadership at The Johns Hopkins University – Carey Business School!

Aruni Ghose: Wonderful friend and academic teammate Shania Makker is bagging the “Best Poster Award” at the ESMO ELCC2024 in Prague

Most viewed in the last 7 days from JAMA Oncology

Matteo Lambertini: Super proud of our University of Genoa, San Martino Polyclinic Hospital group and grateful for the opportunity to actively contribute to ASCO24

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap